You are here

Biosimilars

Biosimilars

Pfizer's Commitment to Biosimilars: To create trusted biosimilar solutions that address the evolving needs of payers, physicians, and patients everywhere

Pfizer's corporate mission for innovative biologics and biosimilars is built upon these key values:

  • Pfizer is committed to advancing science and developing innovative biologics/biosimilars to meet significant unmet medical needs
  • Pfizer believes that the data requirements for the approval of biosimilars should be sufficiently rigorous to ensure patients receive quality products with efficacy and safety profiles that are highly similar to those of the innovator reference products

Learn more about Pfizer Biosimilars

Biosimilars Clinical Trials

The following compounds are being investigated by Pfizer Biosimilars

PF-05280014

PF-05280586

PF-06410293

PF-06438179

PF-06439535